non-compete and covid

What You Need to Know Covid-19 has impacted and continues to impact almost every aspect of our lives, and the business world is no exception. In this blog post, we will discuss how non-compete agreements have been impacted by Covid-19 and what you need to know about them in today’s business environment. Non-compete agreements are…

Read More
SAFE investment

In 2013, startup accelerator, Y Combinator, introduced a new way for investors to invest in startup companies. The Simple Agreement for Future Equity, or SAFE, was created as a simpler alternative to convertible debt and equity investments. Under a SAFE, the investors invest money in the company using a SAFE, in exchange for which, the…

Read More
Mergers and Acquisitions

MORRISVILLE, NC – TrialCard Incorporated, a full-service life sciences company, announced the acquisition of Triangle Insights Group. With this transaction, TrialCard adds a team of experienced professionals who will help continue to provide the highest levels of service.  “The addition of Triangle Insights Group to the TrialCard platform is a huge win for the life…

Read More
Bagchi Intellectual Property Law

Attorney Mayukh Sircar to lead new Intellectual Property Law focus Bagchi Law was founded on the core belief that commercial business clients deserve the expertise of a large law firm, coupled with the care and agile nature of a boutique practice. Today Bagchi Law is announcing the launch of a new business unit that will…

Read More

Bagchi Law is excited to announce our firm has added two new attorneys to the team. Tyler Demasky and Amanda Frazer-Collins recently joined our Chapel Hill law firm, and both will assist in our mission of serving our clients with the expertise of a big law firm, coupled with the care and agile nature of a boutique practice.

Read More

In Part I of our Startup Tax Issues series, we discussed how to avoid penalties with valuations. But what about issues related to 83(b) elections? Startup founders or other service providers receiving restricted stock should strongly consider making an 83(b) election in the year the restricted stock is granted.

Read More

In 2013, there was a slowdown in clinical trials due to clinical trial litigation. Afterward, India experienced an upward trend. Read more about the history of clinical trials and the risks in part I and part II of this series. There are several reasons behind the positive growth in clinical phase 1 and phase 2…

Read More

Although India has made adjustments to match global clinical trial regulation standards, the country still has some work to do. Several grey areas still need to be addressed. In some cases, regulatory authorities are the solution. Other issues require industry practices derived from trial and error. This unfortunately raises significant risk and liability questions. Clinical…

Read More

The emergence of initial coin offerings revolutionized public companies and fundraising. With very few SEC regulations, companies were allowed to raise millions of dollars that weren’t scrutinized by red tape. Companies who were able to sell their vision and coin to the public earned big. However, ICOs are now governed by regulatory bodies that provide…

Read More